Literature DB >> 32600091

Epigenetic regulation of miR-518a-5p-CCR6 feedback loop promotes both proliferation and invasion in diffuse large B cell lymphoma.

Qian Huang1, Feng Zhang1, Haiying Fu1, Jianzhen Shen1.   

Abstract

To investigate the detailed functions and underlying mechanisms of miR-518a-5p/CCR6 in diffuse large B cell lymphoma (DLBCL) is needed. In this study, CCR6 expression levels were tested both in DLBCL cell lines and specimens. Through bioinformatics analysis and quantitative real-time PCR (qRT-PCR) validation, CCR6's targeted miRNA was obtained. Dual luciferase assay was used to verify their targeted relationship. Futhermore, using qRT-PCR, western blot, CCK8, Transwell assays, flow cytometry, pyrosequencing, chromatin immunoprecipitation, and azacitidine/C646 treatment, the detailed functions and underlying mechanisms of CCR6 and its targeted miRNA in DLBCL were detected. We found that negative correlation existed between CCR6 and miR-518a-5p in DLBCL. Both up-regulated miR-518a-5p and down-regulated CCR6 inhibited cell proliferation and invasion in vitro. Experiment then verified the regulatory relationship between miR-518a-5p and CCR6. JAK2 and STAT6 levels were reduced in DLBCL cells transfected with miR-518a-5p mimic or CCR6 small interfering RNA. Interestingly, we showed for the first time that a hyper-methylated condition existed at the promoter region of miR-518a-5p and azacitidine changed levels of miR-518a-5p in a time- and concentration-dependent manner. Finally, we found an enriched histone H3 on lysine 27 acetylation existed in the promoter of CCR6, whose expression could also be changed via C646 in a time- and concentration-dependent manner. The above results suggest that miR-518a-5p-CCR6 feedback loop plays a critical role in DLBCL development. The overexpression of CCR6 is mainly mediated by epigenetic modification through transcriptional and post-transcriptional activation, which provides new directions for DLBCL treatment.

Entities:  

Keywords:  CCR6; diffuse large B cell lymphoma; negative feedback loop; post-transcriptional modification; transcriptional modification

Year:  2020        PMID: 32600091      PMCID: PMC7889247          DOI: 10.1080/15592294.2020.1786317

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  37 in total

1.  Gene annotation and pathway mapping in KEGG.

Authors:  Kiyoko F Aoki-Kinoshita; Minoru Kanehisa
Journal:  Methods Mol Biol       Date:  2007

2.  Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing.

Authors:  Ryan D Morin; Karen Mungall; Erin Pleasance; Andrew J Mungall; Rodrigo Goya; Ryan D Huff; David W Scott; Jiarui Ding; Andrew Roth; Readman Chiu; Richard D Corbett; Fong Chun Chan; Maria Mendez-Lago; Diane L Trinh; Madison Bolger-Munro; Greg Taylor; Alireza Hadj Khodabakhshi; Susana Ben-Neriah; Julia Pon; Barbara Meissner; Bruce Woolcock; Noushin Farnoud; Sanja Rogic; Emilia L Lim; Nathalie A Johnson; Sohrab Shah; Steven Jones; Christian Steidl; Robert Holt; Inanc Birol; Richard Moore; Joseph M Connors; Randy D Gascoyne; Marco A Marra
Journal:  Blood       Date:  2013-05-22       Impact factor: 22.113

3.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

Review 4.  Role of chemokine receptors in thyroid cancer and immunotherapy.

Authors:  Francesca Coperchini; Laura Croce; Michele Marinò; Luca Chiovato; Mario Rotondi
Journal:  Endocr Relat Cancer       Date:  2019-08       Impact factor: 5.678

Review 5.  Epigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment.

Authors:  Antonio Garcia-Gomez; Javier Rodríguez-Ubreva; Esteban Ballestar
Journal:  Clin Immunol       Date:  2018-03-06       Impact factor: 3.969

Review 6.  Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.

Authors:  Nisha Nagarsheth; Max S Wicha; Weiping Zou
Journal:  Nat Rev Immunol       Date:  2017-05-30       Impact factor: 53.106

7.  Next-generation characterization of the Cancer Cell Line Encyclopedia.

Authors:  Mahmoud Ghandi; Franklin W Huang; Judit Jané-Valbuena; Gregory V Kryukov; Christopher C Lo; E Robert McDonald; Jordi Barretina; Ellen T Gelfand; Craig M Bielski; Haoxin Li; Kevin Hu; Alexander Y Andreev-Drakhlin; Jaegil Kim; Julian M Hess; Brian J Haas; François Aguet; Barbara A Weir; Michael V Rothberg; Brenton R Paolella; Michael S Lawrence; Rehan Akbani; Yiling Lu; Hong L Tiv; Prafulla C Gokhale; Antoine de Weck; Ali Amin Mansour; Coyin Oh; Juliann Shih; Kevin Hadi; Yanay Rosen; Jonathan Bistline; Kavitha Venkatesan; Anupama Reddy; Dmitriy Sonkin; Manway Liu; Joseph Lehar; Joshua M Korn; Dale A Porter; Michael D Jones; Javad Golji; Giordano Caponigro; Jordan E Taylor; Caitlin M Dunning; Amanda L Creech; Allison C Warren; James M McFarland; Mahdi Zamanighomi; Audrey Kauffmann; Nicolas Stransky; Marcin Imielinski; Yosef E Maruvka; Andrew D Cherniack; Aviad Tsherniak; Francisca Vazquez; Jacob D Jaffe; Andrew A Lane; David M Weinstock; Cory M Johannessen; Michael P Morrissey; Frank Stegmeier; Robert Schlegel; William C Hahn; Gad Getz; Gordon B Mills; Jesse S Boehm; Todd R Golub; Levi A Garraway; William R Sellers
Journal:  Nature       Date:  2019-05-08       Impact factor: 49.962

8.  CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.

Authors:  Bridget Charbonneau; Alice H Wang; Matthew J Maurer; Yan W Asmann; Clive S Zent; Brian K Link; Stephen M Ansell; George J Weiner; Nazan Ozsan; Andrew L Feldman; Thomas E Witzig; Julie M Cunningham; Ahmet Dogan; Thomas M Habermann; Susan L Slager; Anne J Novak; James R Cerhan
Journal:  Cancer Immunol Immunother       Date:  2013-06-28       Impact factor: 6.968

9.  Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.

Authors:  Bjoern Chapuy; Chip Stewart; Andrew J Dunford; Jaegil Kim; Atanas Kamburov; Robert A Redd; Mike S Lawrence; Margaretha G M Roemer; Amy J Li; Marita Ziepert; Annette M Staiger; Jeremiah A Wala; Matthew D Ducar; Ignaty Leshchiner; Ester Rheinbay; Amaro Taylor-Weiner; Caroline A Coughlin; Julian M Hess; Chandra S Pedamallu; Dimitri Livitz; Daniel Rosebrock; Mara Rosenberg; Adam A Tracy; Heike Horn; Paul van Hummelen; Andrew L Feldman; Brian K Link; Anne J Novak; James R Cerhan; Thomas M Habermann; Reiner Siebert; Andreas Rosenwald; Aaron R Thorner; Matthew L Meyerson; Todd R Golub; Rameen Beroukhim; Gerald G Wulf; German Ott; Scott J Rodig; Stefano Monti; Donna S Neuberg; Markus Loeffler; Michael Pfreundschuh; Lorenz Trümper; Gad Getz; Margaret A Shipp
Journal:  Nat Med       Date:  2018-04-30       Impact factor: 53.440

10.  DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows.

Authors:  Maria D Paraskevopoulou; Georgios Georgakilas; Nikos Kostoulas; Ioannis S Vlachos; Thanasis Vergoulis; Martin Reczko; Christos Filippidis; Theodore Dalamagas; A G Hatzigeorgiou
Journal:  Nucleic Acids Res       Date:  2013-05-16       Impact factor: 16.971

View more
  5 in total

Review 1.  The emerging role non-coding RNAs in B cell-related disorders.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Mohammad Taheri; Elena Jamali
Journal:  Cancer Cell Int       Date:  2022-02-22       Impact factor: 5.722

2.  Weighted gene co-expression network indicates that the DYNLL2 is an important regulator of chicken breast muscle development and is regulated by miR-148a-3p.

Authors:  Guoxi Li; Xiangtao Kang; Yuanfang Li; Pengtao Yuan; Shengxin Fan; Bin Zhai; Wenjiao Jin; Donghua Li; Hong Li; Guirong Sun; Ruili Han; Xiaojun Liu; Yadong Tian
Journal:  BMC Genomics       Date:  2022-04-04       Impact factor: 3.969

Review 3.  Role of microRNAs in B-Cell Compartment: Development, Proliferation and Hematological Diseases.

Authors:  Olívia Fonseca Souza; Ana Flavia Popi
Journal:  Biomedicines       Date:  2022-08-18

4.  Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter's Trans-Formed DLBCL and Germinal Center B-Cells.

Authors:  Barbara Uhl; Katharina T Prochazka; Katrin Pansy; Kerstin Wenzl; Johanna Strobl; Claudia Baumgartner; Marta M Szmyra; James E Waha; Axel Wolf; Peter V Tomazic; Elisabeth Steinbauer; Maria Steinwender; Sabine Friedl; Marc Weniger; Ralf Küppers; Martin Pichler; Hildegard T Greinix; Georg Stary; Alan G Ramsay; Benedetta Apollonio; Julia Feichtinger; Christine Beham-Schmid; Peter Neumeister; Alexander J Deutsch
Journal:  Int J Mol Sci       Date:  2022-07-17       Impact factor: 6.208

5.  miR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin's lymphoma: novel targets with impact on ERK signaling and cell migration.

Authors:  Min Yue Zhang; Lu Qian Wang; Chor Sang Chim
Journal:  Cell Commun Signal       Date:  2021-05-27       Impact factor: 7.525

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.